0.08 (-37.67%)
As of Jan 03, 2023
Source:
We are a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. We target our development programs for the treatment of specific subsets of cancer populations, and simultaneously develop, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use.
Country | United States |
Headquarters | boulder, colorado |
Phone Number | (303) 625-5000 |
Industry | manufacturing |
CEO | /S/ Patrick J. Mahaffy |
Website | clinicaltrials.gov |